These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3491549)

  • 1. Antinuclear antibodies and anti-DNA antibodies in scleroderma. A possible relationship between joint manifestations and increased antibodies in localized scleroderma.
    Serup J; Staun-Olsen P
    Allergy; 1986 Aug; 41(6):452-6. PubMed ID: 3491549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile linear scleroderma associated with serologic abnormalities.
    Woo TY; Rasmussen JE
    Arch Dermatol; 1985 Nov; 121(11):1403-5. PubMed ID: 3876808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies in childhood scleroderma.
    Bernstein RM; Pereira RS; Holden AJ; Black CM; Howard A; Ansell BM
    Ann Rheum Dis; 1985 Aug; 44(8):503-6. PubMed ID: 3875322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinuclear antibodies in localized scleroderma.
    Takehara K; Moroi Y; Nakabayashi Y; Ishibashi Y
    Arthritis Rheum; 1983 May; 26(5):612-6. PubMed ID: 6405756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus.
    Ruffatti A; Peserico A; Rondinone R; Calligaro A; Del Ross T; Ghirardello A; Germino M; Todesco S
    Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to HMG-17 nucleosomal protein in patients with scleroderma.
    Vlachoyiannopoulos PG; Boumba VA; Tzioufas AG; Seferiadis C; Tsolas O; Moutsopoulos HM
    J Autoimmun; 1994 Apr; 7(2):193-201. PubMed ID: 8037838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some immunologic considerations in focal scleroderma and progressive systemic sclerosis in children.
    Hanson V; Kornreich HK; Drexler E; Johnson GD; Macpherson GA
    Pediatr Res; 1974 Sep; 8(9):806-9. PubMed ID: 4213387
    [No Abstract]   [Full Text] [Related]  

  • 9. Antinuclear antibodies in children with localized scleroderma.
    Rosenberg AM; Uziel Y; Krafchik BR; Hauta SA; Prokopchuk PA; Silverman ED; Laxer RM
    J Rheumatol; 1995 Dec; 22(12):2337-43. PubMed ID: 8835572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract]   [Full Text] [Related]  

  • 11. [The antinuclear antibody spectrum in circumscribed forms of scleroderma].
    do Vale E; Gerstmeier H; Meurer M; Krieg T; Braun-Falco O
    Dtsch Med Wochenschr; 1986 Dec; 111(50):1922-7. PubMed ID: 3536401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihistone antibodies in scleroderma.
    Parodi A; Drosera M; Barbieri L; Rebora A
    Dermatology; 1995; 191(1):16-8. PubMed ID: 8589476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of antinuclear antibodies in systemic rheumatic diseases.
    Notman DD; Kurata N; Tan EM
    Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Scleroderma].
    Scharffetter K; Kind P; Wollny-Protzel D; Schuppe HC; Lakomek HJ; Goerz G
    Z Hautkr; 1990 Mar; 65(3):237-42, 245-6. PubMed ID: 2187309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening and studies of the specificity of antinuclear antibodies in lupus erythematosus and scleroderma sera in the tumor cell monolayer substrate].
    Lüthke K; Conrad K; Frank KH
    Dermatol Monatsschr; 1989; 175(8):484-91. PubMed ID: 2676629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea.
    Falanga V; Medsger TA; Reichlin M
    Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized scleroderma-like lesions induced by the Köbner phenomenon in a patient with systemic sclerosis positive for anticentromere antibody.
    Asano Y; Sato S
    Eur J Dermatol; 2020 Aug; 30(4):431-432. PubMed ID: 32808595
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating Fc gamma receptor-specific autoantibodies in localized and systemic scleroderma.
    Davis K; Boros P; Keltz M; Unkeless JC; Fleischmajer R
    J Am Acad Dermatol; 1995 Oct; 33(4):612-6. PubMed ID: 7673494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized scleroderma is an autoimmune disorder.
    Takehara K; Sato S
    Rheumatology (Oxford); 2005 Mar; 44(3):274-9. PubMed ID: 15561734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.